About this trial
This study will include the subjects with symptomatic intracranial arterial stenosis (ICAS) who have participated in and completed the 1-year follow-up of RESIST trial (NCT06615726). The aim is to observe the long-term clinical outcomes over 3 years after a 1-year regular physical exercise intervention in patients with symptomatic ICAS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants who enrolled in the RESIST trial and completed the 12-month follow-up.
Written informed consent to participate in this 3-year observational extension.
Disqualifiers
None
Trial population
This study will include the subjects who enrolled in the RESIST trial.
Trial design
Cohort
Prospective
Treatments tested in this trial
Non-Interventional Study
Other interventionAfter completing 12-month intervention from RESIST trial, investigators would not make any interventions or impact on subjects.
Treatment groups
Trial outcomes
Primary outcomes
New ischemic stroke events
Secondary outcomes
New ischemic stroke and transient ischemic attack events in the responsible vessel supply area
New ischemic stroke and transient ischemic attack events
Hemorrhagic stroke events
Myocardial infarction events
Sponsors and contacts
Click on the lead sponsor to view all of their trials.